Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Diphenhydramine
Drug ID BADD_D00686
Description Diphenhydramine - perhaps known most commonly as its brand name formulation Benadryl - is a first-generation H1 receptor antihistamine that is used extensively for the treatment of seasonal allergies, insect bites and stings, and rashes [L5263, L5266, L5269, F3379]. However, it also has antiemetic, antitussive, hypnotic, and antiparkinson properties [L5269, F3352]. As histamine receptors exist both peripherally and in the central nervous system, diphenhydramine has been shown to cause sedation due to its competitive antagonism of histamine H1 receptors within the central nervous system [L5263, L5266, L5269, F3379, A174541]. While its use in allergy therapy can sometimes fall out of favor due to its sedative effect, diphenhydramine has been repurposed for use within many non-prescription over-the-counter sleep aids and cough-and-cold medications that have been marketed for "night time" use [L5263, L5281, L5287]. Diphenhydramine is also used in combination with [DB14132] as the anti-nausea drug [DB00985] where it is utilized primarily for its antagonism of H1 histamine receptors within the vestibular system [A1540]. Diphenhydramine has also been shown to be implicated in a number of neurotransmitter systems that affect behaviour including dopamine, norepinephrine, serotonin, acetylcholine, and opioid [A1539]. As a result, diphenhydramine is being investigated for its anxiolytic and anti-depressant properties.
Indications and Usage For the treatment of symptoms associated with Vertigo/Meniere's disease, nausea and vomiting, motion sickness and insect bite.
Marketing Status Prescription; Discontinued
ATC Code D04AA32; R06AA02
DrugBank ID DB01075
KEGG ID D00300
MeSH ID D004155
PubChem ID 3100
TTD Drug ID D01FGR
NDC Product Code 52119-012; 76168-065
Synonyms Diphenhydramine | Benzhydramine | Diphenylhydramine | Diphenylhydramin | 2-Diphenylmethoxy-N,N-dimethylethylamine | Benhydramin | Benadryl | Benylin | Diphenhydramine Citrate | Citrate, Diphenhydramine | Diphenhydramine Citrate (1:1) | Diphenhydramine Hydrochloride | Hydrochloride, Diphenhydramine | Dormin | Allerdryl | Dimedrol
Chemical Information
Molecular Formula C17H21NO
CAS Registry Number 58-73-1
SMILES CN(C)CCOC(C1=CC=CC=C1)C2=CC=CC=C2
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Hepatic enzyme increased13.03.01.019--Not Available
Eye movement disorder17.02.05.025; 06.05.02.0080.000758%Not Available
Ischaemia24.04.02.0040.000505%Not Available
Decreased appetite14.03.01.005; 08.01.09.028--
Renal function test abnormal13.13.01.0120.000505%Not Available
Echocardiogram abnormal13.14.02.0020.000505%Not Available
Drug intolerance08.06.01.013--Not Available
Psychotic disorder19.03.01.0020.001516%
Renal impairment20.01.03.010--Not Available
Unevaluable event08.01.03.051--Not Available
Skin abrasion23.03.11.018; 12.01.06.0100.000505%Not Available
Apparent life threatening event18.04.15.001; 17.02.05.043; 22.11.02.0010.000505%Not Available
Gastrointestinal sounds abnormal07.01.01.0020.001010%Not Available
Brain injury19.07.03.007; 17.11.01.0030.000758%Not Available
Oropharyngeal pain22.02.05.022; 07.05.05.004--
Acute kidney injury20.01.03.0160.003537%
Traumatic lung injury22.01.02.013; 12.01.03.0030.000132%Not Available
Hypoxic-ischaemic encephalopathy24.04.06.021; 22.02.02.011; 17.13.02.0060.000593%Not Available
Drug-induced liver injury12.03.01.044; 09.01.07.0230.001263%Not Available
Medication residue present13.15.01.0320.000758%Not Available
Myocardial necrosis marker increased13.04.01.0130.000505%Not Available
Anion gap13.02.01.0180.000198%Not Available
Anion gap abnormal13.02.01.0190.000132%Not Available
Corneal reflex decreased13.07.04.0140.000505%Not Available
Oxygen saturation abnormal13.02.01.0280.000132%Not Available
PCO2 increased13.02.01.0300.000132%Not Available
Pupil fixed17.02.11.008; 06.05.03.0120.003284%Not Available
Respiratory rate increased13.15.01.0040.001263%Not Available
Opsoclonus myoclonus17.13.02.010; 06.05.02.0220.000758%Not Available
Neurogenic shock24.06.02.023; 17.02.10.0250.000505%Not Available
The 11th Page    First    Pre   11 12    Next   Last    Total 12 Pages